Furthermore, in the study by Lee et al., patients with more severe disease (e.g., those receiving anti-TNF agents) were more prone to develop AF compared to the non-severe, suggesting again that systemic inflammation might represent a potential risk factor for AF [87]. Here, TNF is linked to atrial fibrillation.